Cardiac troponin T and creatine kinase MB mass concentrations in children receiving anthracycline chemotherapy
- 1 September 1995
- journal article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 25 (3), 185-189
- https://doi.org/10.1002/mpo.2950250305
Abstract
Anthracyclines (doxorubicin, daunorubicin, and derivatives) are among the most effective antineoplastic drugs for pediatric cancer with dose‐limiting acute and longterm cardiotoxicity. The exact mechanism of the development of cardiomyopathy is still not clear. Anthracyclines may induce subclinical acute myocardial injury leading to lysis of a limited number of myocytes. Alternatively, myocytes may experience a transient loss of cytoplasmic membrane integrity. Both conditions may lead to a transient efflux of small amounts of cytoplasmic enzymes and other proteins specific to the heart muscle fibers. To test these hypotheses we assayed plasma creatine kinase (CK) MB mass and cardiac specific troponin T (TnT). CKMB may be released even in case of reversible cell membrane injury, while prolonged elevation of TnT is the most sensitive and specific marker of limited myocardial necrosis. Thirty‐five anthracycline‐containing chemotherapy courses in 22 children with cancer were analyzed. CKMB mass and TnT concentrations were within the normal range in all children before anthracycline therapy. Within 72 hours from anthracycline therapy no increment of one of these two marker proteins was detected (ANOVA for repeated measures, P = 0.94 [TnT] and 0.25 [CKMB]). We conclude that only minimal if any acute necroses of cardiac myocytes occur after anthracycline therapy. Even membrane integrity appears to be maintained within the first 3 days after anthracycline therapy, in the absence of electrocardiographic or echocardiographic signs of acute cardiotoxicity.Keywords
This publication has 28 references indexed in Scilit:
- MYOCARDIAL INJURY: Cardiac troponin TThe Lancet, 1993
- Childhood cancer, anthracyclines, and the heartThe Lancet, 1992
- Side-branch occlusion during percutaneous transluminal coronary angioplastyThe Lancet, 1992
- Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MBThe American Journal of Cardiology, 1991
- Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarctionThe American Journal of Cardiology, 1991
- Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease.Heart, 1986
- The impact of induction anthracycline on long‐term failure‐free survival in childhood acute lymphoblastic leukemiaMedical and Pediatric Oncology, 1986
- Pharmacotoxic myocardial disease: An endomyocardial studyHeart and Vessels, 1985
- Cardiotoxicity of antitumor agentsProgress in Cardiovascular Diseases, 1984
- Early enzyme release from myocardial cells is not due to irreversible cell damage*Journal of Molecular and Cellular Cardiology, 1984